Status:

COMPLETED

Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy

Lead Sponsor:

Samsung Medical Center

Conditions:

Central Serous Chorioretinopathy

Eligibility:

All Genders

20-80 years

Brief Summary

This study is a comparison of multifocal electroretinogram assessment between the laser treatment group and the photodynamic therapy group in chronic central serous chorioretinopathy.

Detailed Description

1. Laser Group: extrafoveal focal leakage on FAG 2. PDT Group: no definite focal leak on FAG subfoveal or juxtafoveal focal leakage on FAG, or serous retinal pigmentary epithelial detachment involving...

Eligibility Criteria

Inclusion

  • CSC (over 3 months) when subretinal fluid persisted in the subfoveal region demonstrated by clinical examination and OCT
  • Ability to maintain steady fixation for mfERG
  • Presence of abnormal dilated choroidal vasculature in ICGA
  • Symptom duration over 3 months

Exclusion

  • Previous PDT or laser treatment history
  • Evidence of CNV in FAG
  • Other chorioretinal disorders that can cause macular exudation such as age-related macular degeneration, pathologic myopia, angioid streaks, trauma, inflammatory diseases, retinal vasculopathies, and hereditary dystrophies

Key Trial Info

Start Date :

March 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2008

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT00803517

Start Date

March 1 2008

End Date

October 1 2008

Last Update

March 12 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Samsung Medical Center

Seoul, Seoul, South Korea, 135-710